102 related articles for article (PubMed ID: 10581073)
1. Runt domains take the lead in hematopoiesis and osteogenesis.
Werner MH; Shigesada K; Ito Y
Nat Med; 1999 Dec; 5(12):1356-7. PubMed ID: 10581073
[No Abstract] [Full Text] [Related]
2. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
Nagata T; Werner MH
J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761
[TBL] [Abstract][Full Text] [Related]
3. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
Yoshida CA; Furuichi T; Fujita T; Fukuyama R; Kanatani N; Kobayashi S; Satake M; Takada K; Komori T
Nat Genet; 2002 Dec; 32(4):633-8. PubMed ID: 12434152
[TBL] [Abstract][Full Text] [Related]
4. Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia.
Westendorf JJ; Hiebert SW
J Cell Biochem; 1999; Suppl 32-33():51-8. PubMed ID: 10629103
[TBL] [Abstract][Full Text] [Related]
5. Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome.
Nakao M; Horiike S; Fukushima-Nakase Y; Nishimura M; Fujita Y; Taniwaki M; Okuda T
Br J Haematol; 2004 Jun; 125(6):709-19. PubMed ID: 15180860
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain.
Nagata T; Gupta V; Sorce D; Kim WY; Sali A; Chait BT; Shigesada K; Ito Y; Werner MH
Nat Struct Biol; 1999 Jul; 6(7):615-9. PubMed ID: 10404214
[TBL] [Abstract][Full Text] [Related]
7. RUNX genes, neoplasia, and cleidocranial dysplasia.
Cohen MM
Am J Med Genet; 2001 Dec; 104(3):185-8. PubMed ID: 11754042
[No Abstract] [Full Text] [Related]
8. Functional conservation of hematopoietic factors in Drosophila and vertebrates.
Fossett N; Schulz RA
Differentiation; 2001 Dec; 69(2-3):83-90. PubMed ID: 11798069
[TBL] [Abstract][Full Text] [Related]
9. The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp.
Bravo J; Li Z; Speck NA; Warren AJ
Nat Struct Biol; 2001 Apr; 8(4):371-8. PubMed ID: 11276260
[TBL] [Abstract][Full Text] [Related]
10. AML-1 steps up to the platelets.
Irvin BJ; Hiebert SW
Nat Med; 2004 Mar; 10(3):238-9. PubMed ID: 14991045
[No Abstract] [Full Text] [Related]
11. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
12. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia.
Zhang YW; Yasui N; Ito K; Huang G; Fujii M; Hanai J; Nogami H; Ochi T; Miyazono K; Ito Y
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10549-54. PubMed ID: 10962029
[TBL] [Abstract][Full Text] [Related]
13. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
Licht JD
Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817
[No Abstract] [Full Text] [Related]
14. Cleidocranial dysplasia with severe parietal bone dysplasia: C-terminal RUNX2 mutations.
Cunningham ML; Seto ML; Hing AV; Bull MJ; Hopkin RJ; Leppig KA
Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):78-85. PubMed ID: 16463420
[TBL] [Abstract][Full Text] [Related]
15. [Regulation of hematopoiesis by transcription factors].
Kurokawa M; Hirai H
Tanpakushitsu Kakusan Koso; 2000 Jun; 45(9 Suppl):1565-72. PubMed ID: 10879135
[No Abstract] [Full Text] [Related]
16. CBFbeta allosterically regulates the Runx1 Runt domain via a dynamic conformational equilibrium.
Yan J; Liu Y; Lukasik SM; Speck NA; Bushweller JH
Nat Struct Mol Biol; 2004 Sep; 11(9):901-6. PubMed ID: 15322525
[TBL] [Abstract][Full Text] [Related]
17. Upstream and downstream targets of RUNX proteins.
Otto F; Lübbert M; Stock M
J Cell Biochem; 2003 May; 89(1):9-18. PubMed ID: 12682904
[TBL] [Abstract][Full Text] [Related]
18. A new angle on a pervasive oncogene.
Cleary ML
Nat Genet; 1999 Oct; 23(2):134-5. PubMed ID: 10508502
[No Abstract] [Full Text] [Related]
19. Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
Bloomfield CD; Ruppert AS; Mrózek K; Kolitz JE; Moore JO; Mayer RJ; Edwards CG; Sterling LJ; Vardiman JW; Carroll AJ; Pettenati MJ; Stamberg J; Byrd JC; Marcucci G; Larson RA;
Ann Hematol; 2004; 83 Suppl 1():S84-5. PubMed ID: 15124687
[No Abstract] [Full Text] [Related]
20. [Mechanism of leukemogenesis induced by AML 1-MTG 8].
Kitabayashi I; Ohki M
Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):26-32. PubMed ID: 10643332
[No Abstract] [Full Text] [Related]
[Next] [New Search]